Do antidepressants work or don't they? A new study sheds light on why the data on drug treatment are so conflicted.
The antidepressant Prozac may alleviate repetitive behavior and obsessive-compulsive symptoms in adults with autism, reducing these defining symptoms of the disorder, according to new research.
Obsessive compulsive disorder (OCD) can be a nasty enough condition when it strikes an adult. When it hits in childhood it’s far crueler. Not only are kids unequipped to understand what’s happening to them, they are also being denied what should be the best — or at least most worry-free — years of their lives.
Recently, two medical controversies have made headlines: the question of whether too much salt is bad for your health and the debate over whether widely used antidepressant drugs work any better than placebo.
Children whose mothers use antidepressants during pregnancy may be more likely to develop autism than kids whose mothers do not, say researchers in California.
Meet Viibryd, the newest antidepressant to be approved by the Food and Drug Administration (FDA) for major depressive disorder. Some market analysts are already predicting potential annual sales in excess of $1 billion for the new pill. Why?
A new study finds that Prozac can significantly improve recovery from stroke— the number one cause of adult disability and the third leading cause of death in the U.S. The randomized controlled trial found that while patients given placebo for three months starting 5-10 days after a stroke improved 24 points on a 100 point [...]
While the overall benefits of antidepressants for certain patients continue to be debated, new research being presented this week at a meeting of the American Physiological Society in Anaheim, California indicates that patients taking selective serotonin reuptake inhibitors (SSRI) to treat depression may get a side benefit of improved cardiovascular health. In a small [...]
For patients battling severe depression, antidepressant medications are still the best option for treatment, but these drugs may offer little benefit to patients suffering from milder forms of depression, according to a new analysis published this week in the Journal of the American Medical Association. The review, which analyzed data from six previously published placebo-controlled [...]
Clarification added January 6, 2010. A wealth of research has shown that selective serotonin reuptake inhibitors (SSRI) are effective at reducing the symptoms of depression—though new research suggests that study populations limited to those with severe depression may skew these findings, and that antidepressants only show truly significant benefits over placebo in patients with major [...]
